A simple stochastic model for the feedback circuit between p16INK4a and p53 mediated by p38MAPK: implications for senescence and apoptosis

被引:6
|
作者
de Oliveira, L. R. [1 ]
Mombach, J. C. M. [1 ]
Castellani, G. [2 ]
机构
[1] Univ Fed Santa Maria, Dept Phys, BR-97119900 Santa Maria, RS, Brazil
[2] Univ Bologna, Dept Phys, I-40126 Bologna, Italy
关键词
TUMOR-SUPPRESSOR; PROTEIN-KINASE; CELLULAR SENESCENCE; P16(INK4A); EXPRESSION; ACTIVATION; GROWTH; PHOSPHORYLATION; MECHANISM; PATHWAYS;
D O I
10.1039/c5mb00230c
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mechanisms leading to the cell fate decision between apoptosis and senescence upon DNA damage are still unclear and have stochastic features. Cellular oxidative stress can generate DNA damage and activate the important mitogen-activated protein kinase 14 (p38MAPK) that is involved in pathologies like Alzheimer's disease. Based on experimental evidence we propose a simple network that might operate at the core of the cell control machinery for the choice between apoptosis and senescence involving the cross-talk between p38MAPK, the tumor suppressor protein p53 and the cyclin-dependent kinase inhibitor (p16INK4a). We have performed two types of analyses, deterministic and stochastic, exploring the system's parameter space, in the first, we calculated the fixed points of the deterministic model and, in the second, we numerically integrated the master equation for the stochastic version. The model shows a variety of behaviors dependent on the parameters including states of high expression levels of p53 or p16INK4a that can be associated with an apoptotic or senescent phenotype, respectively, in agreement with experimental data. In addition, we observe both monostable and bistable behavior (where bistability is a phenomenon in which two stable steady states coexist for a fixed set of control parameter values) which here we suggest to be involved in the cell fate decision problem.
引用
收藏
页码:2955 / 2963
页数:9
相关论文
共 50 条
  • [1] pRB, p53, p16INK4a senescence and malignant transformation
    Larsen, CJ
    [J]. BULLETIN DU CANCER, 2004, 91 (05) : 399 - 402
  • [2] p16INK4a and p53 deficiency cooperate in tumorigenesis
    Sharpless, NE
    Alson, S
    Chan, S
    Silver, DP
    Castrillon, DH
    DePinho, RA
    [J]. CANCER RESEARCH, 2002, 62 (10) : 2761 - 2765
  • [3] A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
    Hayward, RL
    Smyth, JF
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (17) : 2207 - 2209
  • [4] A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy
    Schmitt, CA
    Fridman, JS
    Yang, M
    Lee, S
    Baranov, E
    Hoffman, RM
    Lowe, SW
    [J]. CELL, 2002, 109 (03) : 335 - 346
  • [5] VentX trans-Activates p53 and p16ink4a to Regulate Cellular Senescence
    Wu, Xiaoming
    Gao, Hong
    Ke, Weixiong
    Hager, Martin
    Xiao, Sheng
    Freeman, Michael R.
    Zhu, Zhenglun
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (14) : 12693 - 12701
  • [6] p16INK4a in cellular senescence
    Simboeck, Elisabeth
    Di Croce, Luciano
    [J]. AGING-US, 2013, 5 (08): : 590 - 591
  • [7] Abnormality of p16/p38MAPK/p53/Wipl pathway in papillary thyroid cancer
    Yang, Dehua
    Zhang, Hao
    Hu, Xinhua
    Xin, Shijie
    Duan, Zhiquan
    [J]. GLAND SURGERY, 2012, 1 (01) : 33 - 38
  • [8] Characterization of a new independent senescence induction path in p53/p21CIP1 and p16INK4A
    Prieur, A.
    Besnard, E.
    Babled, A.
    Lemailre, J. -M.
    [J]. BULLETIN DU CANCER, 2011, 98 : S45 - S45
  • [9] p16Ink4a in melanocyte senescence and differentiation
    Sviderskaya, EV
    Hill, SP
    Evans-Whipp, TJ
    Chin, L
    Orlow, SJ
    Easty, DJ
    Cheong, SC
    Beach, D
    DePinho, RA
    Bennett, DC
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (06) : 446 - 454
  • [10] Regulation of p16INK4a, senescence and oncogenesis
    Chien, Wei Wen
    Ffrench, Martine
    [J]. M S-MEDECINE SCIENCES, 2006, 22 (10): : 865 - 871